This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Black MM, Shuster S, Bottoms E. Skin collagen and thickness in Cushing's syndrome. Arch Dermatol Forsch. 1973;246(4):365–8.
Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. Am J Clin Dermatol. 2002;3(1):47–58.
Burke WA, Briggaman RA, Gammon WR. Epidermolysis bullosa acquisita in a patient with multiple endocrinopathies syndrome. Arch Dermatol. 1986;122(2):187–9.
Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142(5):931–6.
Coßmann M. Messung von Hautatrophie unter vierwöchiger topischer Anwendung verschiedener Glukokortikosteroide mit Optischer Kohärenztomographie, Ultraschall und Profilometrie. Inauguraldissertation Lübeck 2005
Feingold KR, Elias PM. Endocrine-skin interactions. Cutaneous manifestations of adrenal disease, pheochromocytomas, carcinoid syndrome, sex hormone excess and deficiency, polyglandular autoimmune syndromes, multiple endocrine neoplasia syndromes, and other miscellaneous disorders. J Am Acad Dermatol. 1988;19(1 Pt 1):1–20.
Groves RW, MacDonald LM, MacDonald DM. Profound digital collagen atrophy: a new cutaneous presentation of adrenal-dependent Cushing's syndrome. Br J Dermatol. 1990;123(5):667–71.
Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med. 1995;98(2):196–208.
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1–15.
Jabbour SA. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol. 2003;4(5):315–31.
Kendereski A, Micic D, Sumarac M, Zoric S, Macut D, Colic M, Skaro-Milic A, Bogdanovic Z. White Addison's disease: what is the possible cause? J Endocrinol Invest. 1999;22(5):395–400.
Rocha N, Silva E, Horta M, Massa A. Contact allergy to topical corticosteroids 1995–2001. Contact Dermatitis. 2002;47(6):362–3.
Schäcke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002;96(1):23–43.
Schäcke H, Schottelius A, Docke WD, Strehlke P, Jaroch S, Schmees N, Rehwinkel H, Hennekes H, Asadullah K. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci U S A. 2004;101(1):227–32.
Shah SS, Oh CH, Coffin SE, Yan AC. Addisonian pigmentation of the oral mucosa. Cutis. 2005;76(2):97–9.
Sheu HM, Yu HS, Chang CH. Mast cell degranulation and elastolysis in the early stage of striae distensae. J Cutan Pathol 1991;18(6):410–6.
Shibli-Rahhal A, Van Beek M, Schlechte JA. Cushing's syndrome. Clin Dermatol. 2006;24(4):260–5.
Stratakis CA, Mastorakos G, Mitsiades NS, Mitsiades CS, Chrousos GP. Skin manifestations of Cushing disease in children and adolescents before and after the resolution of hypercortisolemia. Pediatr Dermatol. 1998;15(4):253–8.
Sunkel S, Wichmann-Hesse A, Gartner R, Hesse G. Pigmentvermehrung bei Schmidt-Syndrom (polyglanduläres Autoimmunsyndrom Typ II). Hautarzt. 2001;52(10 Pt 2):974–6.
Watson RE, Parry EJ, Humphries JD, Jones CJ, Polson DW, Kielty CM, Griffiths CE. Fibrillin micro-fibrils are reduced in skin exhibiting striae distensae. Br J Dermatol 1998;138(6):931–7.
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2009). Adrenocortical Hormones. In: Cutaneous Manifestations of Endocrine Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-88367-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-540-88367-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-88366-1
Online ISBN: 978-3-540-88367-8
eBook Packages: MedicineMedicine (R0)